Landovská Petra
Faculty of Social Sciences, Institute of Economic Studies, Charles University, Opletalova 26, 110 00, Prague, Czech Republic.
Appl Health Econ Health Policy. 2025 Jan;23(1):141-153. doi: 10.1007/s40258-024-00917-w. Epub 2024 Sep 29.
Smoking is an important risk factor leading to many diseases, which brings substantial healthcare costs as well as indirect costs due to decreased productivity. This article aims to quantify the social costs of smoking in the Czech Republic in 2019.
The prevalence-based, cost-of-illness approach is used, which assesses the costs as the sum of direct (healthcare) costs and indirect costs (productivity losses due to mortality and morbidity). The costs of healthcare utilization and pharmacotherapy in direct costs, and the costs of absenteeism, presenteeism, and premature mortality in indirect costs, are included.
Total costs of smoking in the Czech Republic in 2019 are estimated as 2110.6 million EUR (0.94% of GDP). Direct costs amounted to 537.0 million EUR (2.9% of health expenditures in 2019) and indirect costs were 1573.6 million EUR, mainly driven by the costs of premature mortality (1062.5 million EUR).
Despite the declining trend in the prevalence of smoking in the Czech Republic, the associated costs are considerable. Investments into strategies to reduce smoking continue to be needed.
吸烟是导致多种疾病的重要风险因素，会带来巨额医疗费用以及因生产力下降造成的间接成本。本文旨在量化2019年捷克共和国吸烟造成的社会成本。
采用基于患病率的疾病成本法，该方法将成本评估为直接（医疗保健）成本与间接成本（因死亡率和发病率导致的生产力损失）之和。直接成本包括医疗保健利用和药物治疗的成本，间接成本包括旷工、出勤主义和过早死亡的成本。
2019年捷克共和国吸烟的总成本估计为2.1106亿欧元（占国内生产总值的0.94%）。直接成本为5.37亿欧元（占2019年卫生支出的2.9%），间接成本为15.736亿欧元，主要由过早死亡成本（10.625亿欧元）驱动。
尽管捷克共和国吸烟率呈下降趋势，但相关成本仍然可观。仍需对减少吸烟的策略进行投资。
